← back to search

Mauricio T. Caballero

Foscal Hospital · AR
Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Respiratory viral infections research, Neonatal Respiratory Health Research, Pneumonia and Respiratory Infections, and COVID-19 Clinical Research Studies.
h-index
23
citations
5,719
works
63
NIH funding
primary concept
Medicine
email

Recent publications

Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants
Nature Communications 2025cited by 10position: middledoi
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation
The Lancet Global Health 2025cited by 9position: middledoi
Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies
The Lancet 2024cited by 104position: middledoi
Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina
Vaccine 2024cited by 12position: lastdoi
Corrigendum to “Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina” [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234]
Vaccine 2024cited by 1position: lastdoi
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
The Lancet 2022cited by 1,795position: middledoi
Challenges of Assessing Community Mortality Due to Respiratory Viruses in Children Aged Less Than 5 Years
Clinical Infectious Diseases 2021cited by 20position: firstdoi
Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
The Lancet Global Health 2020cited by 218position: middledoi
Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response
Nature Communications 2019cited by 395position: middledoi
Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors
American Journal of Respiratory and Critical Care Medicine 2016cited by 168position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Clint Pecenka · Seattle University3 papers (2024–2025)Ranju Baral · Seattle University3 papers (2024–2025)Romina Libster · Infant Foundation2 papers (2024–2024) · 2 papers (2024–2024)Sarwat Mahmud · London School of Hygiene & Tropical Medicine2 papers (2024–2024) · 2 papers (2024–2024) · 1 papers (2025–2025)James E. Crowe · Vanderbilt University Medical Center1 papers (2025–2025)Abdul Momin Kazi · Hospital for Sick Children1 papers (2021–2021)Chee Fu Yung · Nanyang Technological University1 papers (2025–2025) · 1 papers (2025–2025)Candice Romero · American Society of Safety Professionals1 papers (2025–2025)Federico Martinón‐Torres · Amsterdam University Medical Centers1 papers (2025–2025)Teresa Bandeira · Universidade Lusófona1 papers (2025–2025)Andrew R. Clark · University of Birmingham1 papers (2024–2024)Qianli Wang · Fudan University1 papers (2025–2025)Joško Markić · Klinički Bolnički Centar Split1 papers (2025–2025)Rachel Pieciak · Boston University1 papers (2021–2021)Janet A. Englund · Seattle Pacific University1 papers (2025–2025)Joyce U. Nyiro · London School of Hygiene & Tropical Medicine1 papers (2025–2025)